Literature DB >> 11733625

Renal function and structure in albuminuric type 2 diabetic patients without retinopathy.

P K Christensen1, S Larsen, T Horn, S Olsen, H H Parving.   

Abstract

BACKGROUND: In type 2 diabetic patients without retinopathy the cause of albuminuria is heterogeneous and our knowledge of the relationship between kidney structure and function in these patients is limited. Therefore, a long-term study evaluating the structural-functional relationship in albuminuric type 2 diabetic patients without retinopathy was performed.
METHODS: Mesangial volume of total glomerular volume (Vv (mes/glom)), fractional area of focal interstitial fibrosis and tubular atrophy of cortical area (FF) and percentage of sclerosed glomeruli (S/G) were measured on kidney biopsies from 49 type 2 diabetic patients without retinopathy. Glomerular filtration rate (GFR) was determined at least 3 times (median 8 (range 3-20)) in each patient. Patients were followed for 7.0 (1.1-17) years. Albuminuria and blood pressure were measured every 3-6 months.
RESULTS: Biopsies revealed diabetic glomerulopathy (DG-group) in 69% of the patients (27 male/7 female) and normal glomerular structure (n=9) or glomerulonephritis (n=6) were found in 31% (13 male/2 female) (NDG-group). In the DG-group GFR decreased from 97+/-5 to 66+/-5 ml/min/1.73 m(2) (mean+/-SE) (P<0.001), with a rate of decline in GFR of 5.3+/-0.8 ml/min/year and in the NDG-group from 93+/-7 to 74+/-11 ml/min/1.73 m(2) (P<0.01), with a rate of decline in GFR of 3.2+/-0.9 ml/min/year, P=0.09 between groups. Mean arterial blood pressure decreased from 109+/-2 to 100+/-2 mm Hg (P<0.001) (DG-group) and remained unchanged in the NDG-group. An association between Vv (mes/glom) and rate of decline in GFR was revealed mainly in the NDG-group (DG-group; r=0.31, P=0.07 and NDG-group; r=0.74, P<0.01). Furthermore, the rate of decline in GFR seemed to be associated with FF in the NDG group (r=0.48, P=0.07). Percentage of S/G was not associated with the rate of decline in GFR. Vv (mes/glom) was associated with mean albuminuria during follow-up in the DG group; r=0.38, P<0.03 (NDG group; r=0.51, P=0.09). Albuminuria was an independent predictor of the rate of decline in GFR in both groups (DG-group; r=0.40, P<0.05 and NDG-group; r=0.61, P<0.01).
CONCLUSIONS: Our study revealed a tendency to a faster rate of decline in GFR in the DG-group compared to the much smaller NDG-group, characterized by marked heterogeneity of the underlying kidney lesions and rate of GFR loss. A large mesangial volume fraction was associated with increased albuminuria and loss in GFR. Albuminuria acted as a progression promoter in both groups.

Entities:  

Mesh:

Year:  2001        PMID: 11733625     DOI: 10.1093/ndt/16.12.2337

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  12 in total

1.  Longitudinal Changes in Measured Glomerular Filtration Rate, Renal Fibrosis and Biomarkers in a Rat Model of Type 2 Diabetic Nephropathy.

Authors:  Zhi Su; Deborah Widomski; Ji Ma; Marian Namovic; Arthur Nikkel; Laura Leys; Lauren Olson; Katherine Salte; Diana Donnelly-Roberts; Timothy Esbenshade; Steve McGaraughty
Journal:  Am J Nephrol       Date:  2016-10-14       Impact factor: 3.754

2.  Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis.

Authors:  F He; X Xia; X F Wu; X Q Yu; F X Huang
Journal:  Diabetologia       Date:  2012-12-12       Impact factor: 10.122

3.  Clinical and Histological Predictors of Renal Survival in Patients with Biopsy-Proven Diabetic Nephropathy.

Authors:  Ting Zhou; Yiyun Wang; Li Shen; Xiaomei Li; Qiong Jiao; Ze Li; Junjie Jia; Li He; Qunzi Zhang; Niansong Wang; Ying Fan
Journal:  Kidney Dis (Basel)       Date:  2021-09-03

4.  Increased renal gene transcription of protein kinase C-beta in human diabetic nephropathy: relationship to long-term glycaemic control.

Authors:  R G Langham; D J Kelly; R M Gow; Y Zhang; A J Cox; W Qi; K Thai; C A Pollock; P K Christensen; H-H Parving; R E Gilbert
Journal:  Diabetologia       Date:  2008-02-16       Impact factor: 10.122

5.  Expression, localization, and function of the thioredoxin system in diabetic nephropathy.

Authors:  Andrew Advani; Richard E Gilbert; Kerri Thai; Renae M Gow; Robyn G Langham; Alison J Cox; Kim A Connelly; Yuan Zhang; Andrew M Herzenberg; Per Knud Christensen; Carol A Pollock; Weier Qi; Sih Min Tan; Hans-Henrik Parving; Darren J Kelly
Journal:  J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 10.121

6.  Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes.

Authors:  Meda E Pavkov; William C Knowler; Robert L Hanson; Peter H Bennett; Robert G Nelson
Journal:  Am J Kidney Dis       Date:  2008-03-20       Impact factor: 8.860

Review 7.  Diabetes and chronic kidney disease: lessons from the Pima Indians.

Authors:  Kevin V Lemley
Journal:  Pediatr Nephrol       Date:  2008-03-05       Impact factor: 3.714

8.  Urine proteome analysis may allow noninvasive differential diagnosis of diabetic nephropathy.

Authors:  Massimo Papale; Salvatore Di Paolo; Riccardo Magistroni; Olga Lamacchia; Anna Maria Di Palma; Angela De Mattia; Maria Teresa Rocchetti; Luciana Furci; Sonia Pasquali; Salvatore De Cosmo; Mauro Cignarelli; Loreto Gesualdo
Journal:  Diabetes Care       Date:  2010-07-29       Impact factor: 17.152

9.  Diabetic nephropathy.

Authors:  Themis Zelmanovitz; Fernando Gerchman; Amely Ps Balthazar; Fúlvio Cs Thomazelli; Jorge D Matos; Luís H Canani
Journal:  Diabetol Metab Syndr       Date:  2009-09-21       Impact factor: 3.320

10.  Identifying parameters to distinguish non-diabetic renal diseases from diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis.

Authors:  Shuang Liang; Xue-Guang Zhang; Guang-Yan Cai; Han-Yu Zhu; Jian-Hui Zhou; Jie Wu; Pu Chen; Shu-Peng Lin; Qiang Qiu; Xiang-Mei Chen
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.